Ivagen launches test for HIV non-progressors
This article was originally published in Clinica
French firm Ivagen has launched in Europe a test to detect anti-R7V antibodies in HIV-positive patients, which will help doctors to identify patients who may be non-progressors - ie those who are infected with the virus but remain asymptomatic.
You may also be interested in...
HAL Allergy Group, developer of products for allergy diagnostics and allergen immunotherapy, promoted its principal scientist to chief R&D officer; Starkey Hearing Technologies brought on new health and business development execs to expand its global footprint; and more.
As the coronavirus continues to spread, one of the big four global vaccines companies has committed itself to the fight.